UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Auricular Vagus Neuromodulation-A Systematic Review on Quality of Evidence and Clinical Effects

Frontiers in neuroscience, 2021-04, Vol.15, p.664740-664740

2021

Link zum Volltext

Verfügbarkeit prüfen

Update on “Cell Therapy” Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S

American journal of ophthalmology, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial

Contemporary clinical trials, 2022-08, Vol.119, p.106804-106804, Article 106804

2022

Link zum Volltext

Verfügbarkeit prüfen

Surgical Experience and Long-Term Results of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction

Seminars in thoracic and cardiovascular surgery, 2016, Vol.28 (2), p.320-328

2016

Link zum Volltext

Verfügbarkeit prüfen

The Baroreceptor as a Therapeutic Target for Heart Failure

Journal of cardiovascular translational research, 2014-04, Vol.7 (3), p.301-309

2014

Link zum Volltext

Verfügbarkeit prüfen

Striking improvement in a case of reduced ejection fraction heart failure with baroreflex activation therapy

Journal of cardiology cases, 2014-07, Vol.10 (1), p.4-6

2014

Link zum Volltext

Verfügbarkeit prüfen

0761 Adaptability of the Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation (OSPREY) Trial

Sleep (New York, N.Y.), 2022-05, Vol.45 (Supplement_1), p.A331-A332

2022

Link zum Volltext

Verfügbarkeit prüfen

Improved Cardiac Structure and Function With Chronic Treatment Using an Implantable Device in Resistant Hypertension

Journal of the American College of Cardiology, 2011-04, Vol.57 (17), p.1787-1788

2011

Link zum Volltext

Verfügbarkeit prüfen

Baroreflex Activation Therapy for Treating Resistant Hypertension and Heart Failure

Transactions of Japanese Society for Medical and Biological Engineering, 2013, Vol.51(Supplement), pp.M-93-M-93

2013

Link zum Volltext

Verfügbarkeit prüfen

0599 Effects of Proximal HGN Stimulation in HTN Subjects with Moderate to Severe OSA: A 5-Year Analysis of the THN3 RCT

Sleep (New York, N.Y.), 2024-04, Vol.47 (Supplement_1), p.A255-A256

2024

Link zum Volltext

Verfügbarkeit prüfen

Design and rationale for the treating obstructive sleep apnea using targeted hypoglossal neurostimulation (OSPREY) trial

Contemporary clinical trials, 2022-08, Vol.119, p.106804-106804

2022

Link zum Volltext

Verfügbarkeit prüfen

Advanced Rhythm Discrimination for Implantable Cardioverter Defibrillators Using Electrogram Vector Timing and Correlation

Journal of cardiovascular electrophysiology, 2002-11, Vol.13 (11), p.1092-1097

2002

Link zum Volltext

Verfügbarkeit prüfen

0453 3-Year Outcomes of Proximal Hypoglossal Nerve Stimulation in the THN3 Controlled Trial

Sleep (New York, N.Y.), 2023-05, Vol.46 (Supplement_1), p.A201-A202

2023

Link zum Volltext

Verfügbarkeit prüfen

Improved Functional Capacity and Cardiovascular Structure after Baroreflex Activation Therapy™ in Resistant Hypertension Patients with Symptomatic Heart Failure: Results from European and United States Trials of the Rheos® System

Journal of cardiac failure, 2009, Vol.15 (6), p.S63-S63

2009

Link zum Volltext

Verfügbarkeit prüfen

Improved Cardiac Structure and Function in Early-Stage Heart Failure with Chronic Treatment Using an Implantable Device: Results from European and United States Trials of the Rheos® System

Journal of cardiac failure, 2008-08, Vol.14 (6), p.S48-S48

2008

Link zum Volltext

Verfügbarkeit prüfen

0765 Enhanced Response to Targeted Hypoglossal Nerve Stimulation in Patients with Normal Sleep Efficiency: A THN3 Post-Hoc Analysis

Sleep (New York, N.Y.), 2022-05, Vol.45 (Supplement_1), p.A333-A333

2022

Link zum Volltext

Verfügbarkeit prüfen

0766 Group Trajectories Demonstrate Robust Effects of Targeted Hypoglossal Nerve Stimulation in the THN3 Randomized, Controlled Trial

Sleep (New York, N.Y.), 2022-05, Vol.45 (Supplement_1), p.A333-A334

2022

Link zum Volltext

Verfügbarkeit prüfen

Time-frequency coherence analysis of atrial fibrillation termination during procainamide administration

Annals of biomedical engineering, 1997-11, Vol.25 (6), p.975-984

1997

Link zum Volltext

Verfügbarkeit prüfen

Baroreflex activation therapy: A new avenue for heart failure treatment

Clinical trials and regulatory science in cardiology, 2016-01, Vol.13, p.34-36

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Experience in Advanced HF Patients Implanted with an Extra-Aortic Counterpulsation Device (EACD)

Journal of cardiac failure, 2016-08, Vol.22 (8), p.S108-S108

2016

Link zum Volltext

Verfügbarkeit prüfen

313 - Clinical Experience in Advanced HF Patients Implanted with an Extra-Aortic Counterpulsation Device (EACD)

Journal of cardiac failure, 2016-08, Vol.22 (8), p.S108-S108

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance of the electrogram vector timing and correlation algorithm for discrimination of ventricular tachycardia from supraventricular tachycardia in patients with wide sinus rhythm QRS

Journal of the American College of Cardiology, 2002-03, Vol.39, p.102-102

2002

Link zum Volltext

Verfügbarkeit prüfen

Baroreflex activation therapy safely reduces blood pressure for at least five years in a large resistant hypertension cohort

Journal of the American Society of Hypertension, 2014-04, Vol.8 (4), p.e9-e9

2014

Link zum Volltext

Verfügbarkeit prüfen

BAROREFLEX ACTIVATION THERAPY REDUCES HOSPITAL RESOURCE UTILIZATION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION

Journal of the American College of Cardiology, 2014-04, Vol.63 (12), p.A923-A923

2014

Link zum Volltext

Verfügbarkeit prüfen

MINIMALLY-INVASIVE SYSTEM FOR BAROREFLEX ACTIVATION THERAPY CHRONICALLY REDUCES BLOOD PRESSURE: INITIAL RESULTS FROM THE BAROSTIM NEO TRIAL

Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E1784-E1784

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 83

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(72)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(83)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(31)
Humans
(27)
Cardiovascular
(10)
Animals
(8)
Biotechnology & Applied Microbiology
(7)
Dna
(6)
Genomics
(6)
Molecular Sequence Data
(6)
Adult
(5)
Baroreflex
(5)
Biochemistry & Molecular Biology
(5)
Biological And Medical Sciences
(5)
Cardiology
(5)
Female
(5)
Genetics & Heredity
(5)
Heart Failure
(5)
Internal Medicine
(5)
Multidisciplinary Sciences
(5)
Science & Technology - Other Topics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Auricular Vagus Neuromodulation-A Systematic Review on Quality of Evidence and Clinical Effects

Update on “Cell Therapy” Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S

Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial

Surgical Experience and Long-Term Results of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction

The Baroreceptor as a Therapeutic Target for Heart Failure

Striking improvement in a case of reduced ejection fraction heart failure with baroreflex activation therapy

0761 Adaptability of the Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation (OSPREY) Trial

Improved Cardiac Structure and Function With Chronic Treatment Using an Implantable Device in Resistant Hypertension

Baroreflex Activation Therapy for Treating Resistant Hypertension and Heart Failure

0599 Effects of Proximal HGN Stimulation in HTN Subjects with Moderate to Severe OSA: A 5-Year Analysis of the THN3 RCT

Design and rationale for the treating obstructive sleep apnea using targeted hypoglossal neurostimulation (OSPREY) trial

Advanced Rhythm Discrimination for Implantable Cardioverter Defibrillators Using Electrogram Vector Timing and Correlation

0453 3-Year Outcomes of Proximal Hypoglossal Nerve Stimulation in the THN3 Controlled Trial

Improved Functional Capacity and Cardiovascular Structure after Baroreflex Activation Therapy™ in Resistant Hypertension Patients with Symptomatic Heart Failure: Results from European and United States Trials of the Rheos® System

Improved Cardiac Structure and Function in Early-Stage Heart Failure with Chronic Treatment Using an Implantable Device: Results from European and United States Trials of the Rheos® System

0765 Enhanced Response to Targeted Hypoglossal Nerve Stimulation in Patients with Normal Sleep Efficiency: A THN3 Post-Hoc Analysis

0766 Group Trajectories Demonstrate Robust Effects of Targeted Hypoglossal Nerve Stimulation in the THN3 Randomized, Controlled Trial

Time-frequency coherence analysis of atrial fibrillation termination during procainamide administration

Baroreflex activation therapy: A new avenue for heart failure treatment

Clinical Experience in Advanced HF Patients Implanted with an Extra-Aortic Counterpulsation Device (EACD)

313 - Clinical Experience in Advanced HF Patients Implanted with an Extra-Aortic Counterpulsation Device (EACD)

Performance of the electrogram vector timing and correlation algorithm for discrimination of ventricular tachycardia from supraventricular tachycardia in patients with wide sinus rhythm QRS

Baroreflex activation therapy safely reduces blood pressure for at least five years in a large resistant hypertension cohort

BAROREFLEX ACTIVATION THERAPY REDUCES HOSPITAL RESOURCE UTILIZATION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION

MINIMALLY-INVASIVE SYSTEM FOR BAROREFLEX ACTIVATION THERAPY CHRONICALLY REDUCES BLOOD PRESSURE: INITIAL RESULTS FROM THE BAROSTIM NEO TRIAL

Aktive Filter

Suchergebnisse filtern